Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2026-01-25 @ 10:59 PM
Study NCT ID:
NCT01125566
Status:
COMPLETED
Last Update Posted:
2019-07-18
First Post:
2010-05-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Sponsor:
Boehringer Ingelheim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Neoplasms | View |
Keywords: